Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Desmin is an intermediate filament protein typically associated with autosomal dominant myofibrillar myopathy with cardiac involvement.
|
31024060 |
2019 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Desmin-associated myofibrillar myopathy (MFM) has pathologic similarities to neurodegeneration-associated protein aggregate diseases.
|
31371504 |
2019 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
We propose that in MFM horses, altered cysteine metabolism and a deficiency of cysteine-containing antioxidants combined with a high capacity to oxidize fatty acids and generate ROS during aerobic exercise causes chronic oxidation and aggregation of key proteins such as desmin.
|
30289745 |
2018 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
CTD_human |
229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017.
|
30055862 |
2018 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Familial PAM includes myofibrillar myopathies defined by the presence of desmin-positive protein aggregates and degenerative intermyofibrillar network changes.
|
29924655 |
2018 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Skeletal muscle biopsy revealed the morphological picture of myofibrillar myopathy with sarcoplasmic aggregates, immunoreactive for desmin and other ectopic proteins on immunohistochemistry, appearing as granulofilamentous material at ultrastructural level.
|
28523323 |
2017 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Our data suggest that mutated desmin already markedly impedes myocyte structure and function at pre-symptomatic stages of myofibrillar myopathies.
|
28469177 |
2017 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Desmin-related cardiomyopathy is a heterogeneous group of myofibrillar myopathies characterized by aggregates of desmin and related proteins in myocytes.
|
28341603 |
2017 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Desminopathies belong to a family of muscle disorders called myofibrillar myopathies that are caused by Desmin mutations and lead to protein aggregates in muscle fibers.
|
26051936 |
2015 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Two desmin gene mutations associated with myofibrillar myopathies in Polish families.
|
25541946 |
2014 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Desmin, the muscle-specific intermediate filament, is involved in myofibrillar myopathies, dilated cardiomyopathy and muscle wasting.
|
24091796 |
2014 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Variants in the desmin gene (DES) are associated with desminopathy; a myofibrillar myopathy mainly characterized by muscle weakness, conduction block, and dilated cardiomyopathy.
|
23815709 |
2013 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Three mutant desmin variants were detected directly on the protein level as components of the aggregates, suggesting their direct involvement in aggregate-formation and demonstrating for the first time that proteomic analysis can be used for direct identification of a disease-causing mutation in myofibrillar myopathy.
|
23639843 |
2013 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Here, we analyse myoblasts behaviour in the context of myofibrillar myopathy resulting from p.D399Y desmin mutation which disorganizes the desmin IF network in muscle cells.
|
23234811 |
2013 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations within the human desmin gene are responsible for a subcategory of myofibrillar myopathies called desminopathies.
|
24098483 |
2013 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Dependent on the MFM causing mutation, different sets of proteins were revealed as genuine (accumulated) plaque components in independent technical replicates: (i) αB-crystallin, desmin, filamin A/C, myotilin, PRAF3, RTN2, SQSTM, XIRP1, and XIRP2 (patient with defined MFM mutation distinct from FHL1) or (ii) desmin, FHL1, filamin A/C, KBTBD10, NRAP, SQSTM, RL40, XIRP1, and XIRP2 (patient with FHL1 mutation).
|
23044792 |
2012 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study.
|
22153487 |
2012 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Disease associated with mutations in filamin C rod domain leading to expression of a toxic protein presents with progressive proximal muscle weakness and shows focal destructive lesions of polymorphous aggregates containing desmin, myotilin and other proteins in the affected myofibres; these features correspond to the profile of myofibrillar myopathy.
|
22961544 |
2012 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
CTD_human |
Desmin-related myopathy.
|
20718792 |
2011 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Divergent molecular effects of desmin mutations on protein assembly in myofibrillar myopathy.
|
20448486 |
2010 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Muscle biopsy demonstrated signs of myofibrillar myopathy with prominent subsarcolemmal desmin-reactive aggregates.
|
19433360 |
2009 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the desmin gene cause myofibrillar myopathy characterized by desmin-positive aggregates and myofibrillar dissolution.
|
19763525 |
2009 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
While MFMs are partly caused by mutations in genes encoding for extramyofibrillar proteins (desmin, alphaB-crystallin, plectin) or myofibrillar proteins (myotilin, Z-band alternatively spliced PDZ-containing protein, filamin C, Bcl-2-associated athanogene-3, four-and-a-half LIM domain 1), a large number of these diseases are caused by still unresolved gene defects.
|
19563540 |
2009 |
Myofibrillar Myopathy
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The ultrastructural findings in 19 patients with different genetically proven MFMs (9 desmin, 5 alphaB-crystallin, 3 ZASP, 2 myotilin) were analyzed.
|
18653338 |
2008 |
Myofibrillar Myopathy
|
0.700 |
Biomarker
|
disease |
BEFREE |
Skeletal and cardiac muscle from patients with primary desminopathies characteristically display cytoplasmic accumulation of desmin-immunoreactive material and myofibrillar changes.
|
17635637 |
2007 |